Aviva PLC Bio Techne Corp Transaction History

Aviva PLC

$36.8 Billion
Q4 2024

A detailed history of Aviva PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Aviva PLC holds 95,063 shares of TECH stock, worth $6.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

95,063

Previous 5,774 1546.4%

Holding current value

$6.27 Million

Previous $461,000 1385.25%

% of portfolio

0.02%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$66.37 - $78.17 $5.93 Million - $6.98 Million	89,289 Added 1546.4%	95,063 $6.85 Million
Q3 2024 Nov 14, 2024	SELL	$70.96 - $82.35 $1,277 - $1,482	-18 Reduced 0.31%	5,774 $461,000
Q2 2024 Aug 02, 2024	SELL	$62.12 - $84.15 $1,987 - $2,692	-32 Reduced 0.55%	5,792 $414,000
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $923 - $1,079	-14 Reduced 0.24%	5,824 $409,000
Q4 2023 Feb 09, 2024	SELL	$52.83 - $78.22 $435,794 - $645,236	-8,249 Reduced 58.56%	5,838 $450,000
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $609,975 - $807,820	-9,034 Reduced 39.07%	14,087 $958,000
Q2 2023 Aug 10, 2023	SELL	$73.76 - $85.98 $10 Million - $11.7 Million	-135,934 Reduced 85.46%	23,121 $1.89 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $9.01 Million - $10.9 Million	125,740 Added 377.43%	159,055 $11.8 Million
Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $1.86 Million - $8.12 Million	23,037 Added 224.14%	33,315 $2.76 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $1.88 Million - $2.6 Million	-6,642 Reduced 39.26%	10,278 $2.92 Million
Q2 2022 Aug 04, 2022	SELL	$322.67 - $449.65 $121,969 - $169,967	-378 Reduced 2.19%	16,920 $5.87 Million
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $549,175 - $757,050	1,552 Added 9.86%	17,298 $7.49 Million
Q4 2021 Feb 10, 2022	BUY	$456.15 - $525.06 $1.79 Million - $2.06 Million	3,915 Added 33.09%	15,746 $8.15 Million
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $2.92 Million - $3.54 Million	6,566 Added 124.71%	11,831 $5.73 Million
Q2 2021 Aug 10, 2021	BUY	$387.35 - $450.26 $791,743 - $920,331	2,044 Added 63.46%	5,265 $2.37 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $615,711 - $804,327	-1,957 Reduced 37.79%	3,221 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$246.9 - $321.87 $1.04 Million - $1.35 Million	-4,197 Reduced 44.77%	5,178 $1.64 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $87,779 - $106,958	378 Added 4.2%	9,375 $2.32 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $2 Million - $3.01 Million	-10,760 Reduced 54.46%	8,997 $2.38 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $1.79 Million - $2.46 Million	11,085 Added 127.83%	19,757 $3.75 Million
Q4 2019 Feb 10, 2020	BUY	$189.68 - $222.09 $1.64 Million - $1.93 Million	8,672 New	8,672 $1.9 Million

Others Institutions Holding TECH

# of Institutions

616

Shares Held

156M

Call Options Held

200K

Put Options Held

15.3K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account